Transposon Therapeutics, a biotechnology company developing a platform of novel, orally administered therapies for the treatment of neurodegenerative and aging-related diseases, including Alzheimer's ...

"I want people to know that when I hear from another family affected by FTD, I hear our family's same story of grief, loss, ...

Over her career, she has held leadership roles in both academic and industry settings where she advanced clinical programs for diseases like AD, frontotemporal dementia (FTD) and PD. Prior to joining ...

AbbVie has an exclusive option to globally develop and commercialize AL002. Alector will deliver a data package resulting ...

It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer’s disease, and Parkinson’s disease. The company was founded by Asa ...

TD Cowen analyst Yaron Werber has maintained their bullish stance on ALEC stock, giving a Buy rating on November 4. Yaron Werber has given his ...

Cisco published 15 new security announcements on Thursday night. They cover a whole range of products. These include one ...

Researchers at Monash University are conducting clinical trials of a drug that promises to be a game-changer for sufferers of ...

Critical Path Institute today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine Tatton, Ph.D., has been welcomed as the new ...

Due to this medical history, Emma said she initially ignored the early warning signs. “As his language started changing, it ...

Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a ...

Detailed price information for Denali Therapeutics Inc (DNLI-Q) from The Globe and Mail including charting and trades.